
AVALYN PHARMA INC
AVLN · NASDAQ
Updated at 2026-10-15 11:19:34
- Today's High
- $24.14
- Today’s Low
- $22.68
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $23.69
- Previous Close
- $23.69
- Volume
- 267.77K
- Market Cap
- $1.05B
- P/E Ratio
- --
- EPS
- --
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Pharmaceuticals
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 105 W FIRST STREET, BOSTON, MA, UNITED STATES, 02127
- Country
- US
- Listing Date
- 2026-04-30
- Fiscal Year End
- December
- Shares Outstanding
- 44.33M
- CIK
- --
- Website
- www.avalynpharma.com
Avalyn Pharma Inc. is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for severe respiratory diseases, with its lead candidate, AV-101, specifically targeting the underlying causes of lung inflammation and fibrosis. The company addresses critical unmet medical needs in respiratory health through a robust pipeline and a commitment to next-generation treatment solutions. With an experienced leadership team and a distinguished scientific advisory board, Avalyn is strategically positioned to enhance patient outcomes and capture an expanding market in respiratory therapeutics.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-06-30
$0
2025-03-31
$0
Operating Expenses
2026-06-30
$31.18M
2026-03-31
$27.9M
2025-06-30
$21.77M
2025-03-31
$18.71M
Net Income
2026-06-30
-$28.93M
2026-03-31
-$26.86M
2025-06-30
-$20.19M
2025-03-31
-$17.5M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-06-30
--
2025-03-31
--
Earnings Per Share
2026-06-30
$-0.98
2026-03-31
$-21.83
2025-06-30
--
2025-03-31
--
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$31.18M
2026-03-31
-$26.7M
2025-06-30
-$20.18M
2025-03-31
-$17.49M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-06-30
--
2025-03-31
--
| Item | 2026-06-30 | 2026-03-31 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $31.18M | $27.9M | $21.77M | $18.71M |
| Net Income | -$28.93M | -$26.86M | -$20.19M | -$17.5M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-0.98 | $-21.83 | -- | -- |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$31.18M | -$26.7M | -$20.18M | -$17.49M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.